Joseph Lucchese serves as Executive at Timber Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Joseph Lucchese has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 20, 2023 involved receiving (via award) 35,193 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 20, 2023 | TMBR | $0 | Award | 35,193 | $N/A | Discretionary |
Joseph Lucchese currently holds 35,193 shares of Timber Pharmaceuticals, Inc. (TMBR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Lucchese has been a net neutral trader of TMBR stock. They have purchased $0 and sold $0 worth of shares.
Joseph Lucchese's most recent insider trade was on Aug 20, 2023, when they sold 35,193 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted